Analysts at StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Trading Down 0.7 %
NASDAQ CHEK opened at $1.48 on Wednesday. The company has a market cap of $8.66 million, a P/E ratio of -0.49 and a beta of 0.36. The company has a fifty day simple moving average of $1.69 and a 200 day simple moving average of $2.01. Check-Cap has a 12-month low of $1.13 and a 12-month high of $3.94.
About Check-Cap
See Also
- Five stocks we like better than Check-Cap
- How to Calculate Options Profits
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to invest in marijuana stocks in 7 steps
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Using the MarketBeat Stock Split Calculator
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.